Growth Metrics

Boston Scientific (BSX) Total Non-Current Liabilities (2016 - 2025)

Boston Scientific (BSX) has disclosed Total Non-Current Liabilities for 17 consecutive years, with $16.8 billion as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 6.61% to $16.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.8 billion through Dec 2025, up 6.61% year-over-year, with the annual reading at $16.8 billion for FY2025, 6.61% up from the prior year.
  • Total Non-Current Liabilities hit $16.8 billion in Q4 2025 for Boston Scientific, up from $16.7 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $39.2 billion in Q2 2025 to a low of $8.8 billion in Q1 2021.
  • Historically, Total Non-Current Liabilities has averaged $24.6 billion across 5 years, with a median of $29.5 billion in 2021.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 243.0% in 2022 and later crashed 56.26% in 2023.
  • Year by year, Total Non-Current Liabilities stood at $32.3 billion in 2021, then fell by 3.34% to $31.2 billion in 2022, then plummeted by 56.26% to $13.6 billion in 2023, then increased by 15.51% to $15.8 billion in 2024, then rose by 6.61% to $16.8 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for BSX at $16.8 billion in Q4 2025, $16.7 billion in Q3 2025, and $39.2 billion in Q2 2025.